No Prescription |
 |
 | ||
|
Memantine NAMENDA |
|
| ||
No Prescription » Prescription Drugs 10 » Memantine NAMENDA Memantine is used to treat moderate to severe confusion (dementia) related to Alzheimer's disease. It does not cure Alzheimer's disease but it may improve memory awareness and the ability to perform daily functions. This medication works by blocking the action of a certain natural substance in the brain (glutamate) that is believed to be linked to symptoms of Alzheimer's disease.How to use Memantine OralTake this medication by mouth with or without food. When you first start taking this medication you will usually take it once daily. Your dose will be gradually increased to lower the risk of side effects. Once your dose increases to more than 5 milligrams per day take this medication twice daily or as directed by your doctor.If you are taking memantine oral liquid read the manufacturer's instruction sheet that comes with the bottle. Follow the directions exactly. Use the oral syringe that comes with the product to measure out your dose. Swallow the medication directly from the syringe. Do not mix it with water or other liquids. Rinse the syringe with water after each use. Consult your doctor or pharmacist if you have any questions.Use this medication regularly in order to get the most benefit from it. Do not stop taking it or increase the dosage unless your doctor instructs you to do so.Inform your doctor if your condition worsens.Memantine Oral is used to treat the following:Moderate to Severe Alzheimer's Type Dementia Buy Memantine NAMENDA and other Prescription Drugs 10 products online at Medstore. Buy Online at Medstore - Click Here!
About Memantine NAMENDA: Product Type: Prescription Drugs 10 Memantine ( NAMENDA Generic Memantine ) Memantine (NAMENDA Generic Memantine) NAMENDA Generic Memantine 10mg NAMENDA Generic Memantine Memantine
View more Prescription Drugs 10 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
